✦ LIBER ✦
A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal
✍ Scribed by Elmer Yu; Karen Miotto; Evaristo Akerele; Ann Montgomery; Ahmed Elkashef; Robert Walsh; Ivan Montoya; Marian W. Fischman; Joseph Collins; Frances McSherry; Kathy Boardman; David K. Davies; Charles P. O’Brien; Walter Ling; Herbert Kleber; Barbara H. Herman
- Book ID
- 116412104
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 656 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0376-8716
No coin nor oath required. For personal study only.